Global Gestational Diabetes Treatment Market Insights, Forecast to 2028

Report ID: 1754098 | Published Date: Jan 2025 | No. of Page: 118 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gestational Diabetes Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Insulin
        1.2.3 SGLT-2 Inhibitors
        1.2.4 Alpha-glucosidase Inhibitors
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Gestational Diabetes Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gestational Diabetes Treatment Market Perspective (2017-2028)
    2.2 Gestational Diabetes Treatment Growth Trends by Region
        2.2.1 Gestational Diabetes Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gestational Diabetes Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Gestational Diabetes Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Gestational Diabetes Treatment Market Dynamics
        2.3.1 Gestational Diabetes Treatment Industry Trends
        2.3.2 Gestational Diabetes Treatment Market Drivers
        2.3.3 Gestational Diabetes Treatment Market Challenges
        2.3.4 Gestational Diabetes Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gestational Diabetes Treatment Players by Revenue
        3.1.1 Global Top Gestational Diabetes Treatment Players by Revenue (2017-2022)
        3.1.2 Global Gestational Diabetes Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Gestational Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gestational Diabetes Treatment Revenue
    3.4 Global Gestational Diabetes Treatment Market Concentration Ratio
        3.4.1 Global Gestational Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gestational Diabetes Treatment Revenue in 2021
    3.5 Gestational Diabetes Treatment Key Players Head office and Area Served
    3.6 Key Players Gestational Diabetes Treatment Product Solution and Service
    3.7 Date of Enter into Gestational Diabetes Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gestational Diabetes Treatment Breakdown Data by Type
    4.1 Global Gestational Diabetes Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Gestational Diabetes Treatment Forecasted Market Size by Type (2023-2028)
5 Gestational Diabetes Treatment Breakdown Data by Application
    5.1 Global Gestational Diabetes Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Gestational Diabetes Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gestational Diabetes Treatment Market Size (2017-2028)
    6.2 North America Gestational Diabetes Treatment Market Size by Type
        6.2.1 North America Gestational Diabetes Treatment Market Size by Type (2017-2022)
        6.2.2 North America Gestational Diabetes Treatment Market Size by Type (2023-2028)
        6.2.3 North America Gestational Diabetes Treatment Market Share by Type (2017-2028)
    6.3 North America Gestational Diabetes Treatment Market Size by Application
        6.3.1 North America Gestational Diabetes Treatment Market Size by Application (2017-2022)
        6.3.2 North America Gestational Diabetes Treatment Market Size by Application (2023-2028)
        6.3.3 North America Gestational Diabetes Treatment Market Share by Application (2017-2028)
    6.4 North America Gestational Diabetes Treatment Market Size by Country
        6.4.1 North America Gestational Diabetes Treatment Market Size by Country (2017-2022)
        6.4.2 North America Gestational Diabetes Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Gestational Diabetes Treatment Market Size (2017-2028)
    7.2 Europe Gestational Diabetes Treatment Market Size by Type
        7.2.1 Europe Gestational Diabetes Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Gestational Diabetes Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Gestational Diabetes Treatment Market Share by Type (2017-2028)
    7.3 Europe Gestational Diabetes Treatment Market Size by Application
        7.3.1 Europe Gestational Diabetes Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Gestational Diabetes Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Gestational Diabetes Treatment Market Share by Application (2017-2028)
    7.4 Europe Gestational Diabetes Treatment Market Size by Country
        7.4.1 Europe Gestational Diabetes Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Gestational Diabetes Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gestational Diabetes Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Type
        8.2.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Gestational Diabetes Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Gestational Diabetes Treatment Market Size by Application
        8.3.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Gestational Diabetes Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Gestational Diabetes Treatment Market Size by Region
        8.4.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Gestational Diabetes Treatment Market Size (2017-2028)
    9.2 Latin America Gestational Diabetes Treatment Market Size by Type
        9.2.1 Latin America Gestational Diabetes Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Gestational Diabetes Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Gestational Diabetes Treatment Market Share by Type (2017-2028)
    9.3 Latin America Gestational Diabetes Treatment Market Size by Application
        9.3.1 Latin America Gestational Diabetes Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Gestational Diabetes Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Gestational Diabetes Treatment Market Share by Application (2017-2028)
    9.4 Latin America Gestational Diabetes Treatment Market Size by Country
        9.4.1 Latin America Gestational Diabetes Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Gestational Diabetes Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gestational Diabetes Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type
        10.2.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Gestational Diabetes Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Application
        10.3.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Gestational Diabetes Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Gestational Diabetes Treatment Market Size by Country
        10.4.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Biocon Limited
        11.1.1 Biocon Limited Company Details
        11.1.2 Biocon Limited Business Overview
        11.1.3 Biocon Limited Gestational Diabetes Treatment Introduction
        11.1.4 Biocon Limited Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.1.5 Biocon Limited Recent Developments
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Details
        11.2.2 Eli Lilly Business Overview
        11.2.3 Eli Lilly Gestational Diabetes Treatment Introduction
        11.2.4 Eli Lilly Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.2.5 Eli Lilly Recent Developments
    11.3 Novo Nordisk
        11.3.1 Novo Nordisk Company Details
        11.3.2 Novo Nordisk Business Overview
        11.3.3 Novo Nordisk Gestational Diabetes Treatment Introduction
        11.3.4 Novo Nordisk Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.3.5 Novo Nordisk Recent Developments
    11.4 Boehringer Ingelheim GmbH
        11.4.1 Boehringer Ingelheim GmbH Company Details
        11.4.2 Boehringer Ingelheim GmbH Business Overview
        11.4.3 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Introduction
        11.4.4 Boehringer Ingelheim GmbH Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.4.5 Boehringer Ingelheim GmbH Recent Developments
    11.5 Sanofi S.A.
        11.5.1 Sanofi S.A. Company Details
        11.5.2 Sanofi S.A. Business Overview
        11.5.3 Sanofi S.A. Gestational Diabetes Treatment Introduction
        11.5.4 Sanofi S.A. Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.5.5 Sanofi S.A. Recent Developments
    11.6 Sun Pharmaceutical Industries Limited
        11.6.1 Sun Pharmaceutical Industries Limited Company Details
        11.6.2 Sun Pharmaceutical Industries Limited Business Overview
        11.6.3 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Introduction
        11.6.4 Sun Pharmaceutical Industries Limited Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.6.5 Sun Pharmaceutical Industries Limited Recent Developments
    11.7 Merck
        11.7.1 Merck Company Details
        11.7.2 Merck Business Overview
        11.7.3 Merck Gestational Diabetes Treatment Introduction
        11.7.4 Merck Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.7.5 Merck Recent Developments
    11.8 Novartis
        11.8.1 Novartis Company Details
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Gestational Diabetes Treatment Introduction
        11.8.4 Novartis Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.8.5 Novartis Recent Developments
    11.9 Adocia
        11.9.1 Adocia Company Details
        11.9.2 Adocia Business Overview
        11.9.3 Adocia Gestational Diabetes Treatment Introduction
        11.9.4 Adocia Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.9.5 Adocia Recent Developments
    11.10 Peptron
        11.10.1 Peptron Company Details
        11.10.2 Peptron Business Overview
        11.10.3 Peptron Gestational Diabetes Treatment Introduction
        11.10.4 Peptron Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.10.5 Peptron Recent Developments
    11.11 AstraZeneca plc
        11.11.1 AstraZeneca plc Company Details
        11.11.2 AstraZeneca plc Business Overview
        11.11.3 AstraZeneca plc Gestational Diabetes Treatment Introduction
        11.11.4 AstraZeneca plc Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.11.5 AstraZeneca plc Recent Developments
    11.12 Pfizer, Inc
        11.12.1 Pfizer, Inc Company Details
        11.12.2 Pfizer, Inc Business Overview
        11.12.3 Pfizer, Inc Gestational Diabetes Treatment Introduction
        11.12.4 Pfizer, Inc Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.12.5 Pfizer, Inc Recent Developments
    11.13 Takeda Pharmaceutical Company Ltd
        11.13.1 Takeda Pharmaceutical Company Ltd Company Details
        11.13.2 Takeda Pharmaceutical Company Ltd Business Overview
        11.13.3 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Introduction
        11.13.4 Takeda Pharmaceutical Company Ltd Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.13.5 Takeda Pharmaceutical Company Ltd Recent Developments
    11.14 Abbott
        11.14.1 Abbott Company Details
        11.14.2 Abbott Business Overview
        11.14.3 Abbott Gestational Diabetes Treatment Introduction
        11.14.4 Abbott Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.14.5 Abbott Recent Developments
    11.15 Antares Pharma
        11.15.1 Antares Pharma Company Details
        11.15.2 Antares Pharma Business Overview
        11.15.3 Antares Pharma Gestational Diabetes Treatment Introduction
        11.15.4 Antares Pharma Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.15.5 Antares Pharma Recent Developments
    11.16 INJEX Pharma AG
        11.16.1 INJEX Pharma AG Company Details
        11.16.2 INJEX Pharma AG Business Overview
        11.16.3 INJEX Pharma AG Gestational Diabetes Treatment Introduction
        11.16.4 INJEX Pharma AG Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.16.5 INJEX Pharma AG Recent Developments
    11.17 Daiichi Sankyo
        11.17.1 Daiichi Sankyo Company Details
        11.17.2 Daiichi Sankyo Business Overview
        11.17.3 Daiichi Sankyo Gestational Diabetes Treatment Introduction
        11.17.4 Daiichi Sankyo Revenue in Gestational Diabetes Treatment Business (2017-2022)
        11.17.5 Daiichi Sankyo Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Gestational Diabetes Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Insulin
    Table 3. Key Players of SGLT-2 Inhibitors
    Table 4. Key Players of Alpha-glucosidase Inhibitors
    Table 5. Key Players of Others
    Table 6. Global Gestational Diabetes Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Gestational Diabetes Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Gestational Diabetes Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Gestational Diabetes Treatment Market Share by Region (2017-2022)
    Table 10. Global Gestational Diabetes Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Gestational Diabetes Treatment Market Share by Region (2023-2028)
    Table 12. Gestational Diabetes Treatment Market Trends
    Table 13. Gestational Diabetes Treatment Market Drivers
    Table 14. Gestational Diabetes Treatment Market Challenges
    Table 15. Gestational Diabetes Treatment Market Restraints
    Table 16. Global Gestational Diabetes Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Gestational Diabetes Treatment Revenue Share by Players (2017-2022)
    Table 18. Global Top Gestational Diabetes Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gestational Diabetes Treatment as of 2021)
    Table 19. Ranking of Global Top Gestational Diabetes Treatment Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Gestational Diabetes Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Gestational Diabetes Treatment Product Solution and Service
    Table 23. Date of Enter into Gestational Diabetes Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Gestational Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Gestational Diabetes Treatment Revenue Market Share by Type (2017-2022)
    Table 27. Global Gestational Diabetes Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Gestational Diabetes Treatment Revenue Market Share by Type (2023-2028)
    Table 29. Global Gestational Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Gestational Diabetes Treatment Revenue Share by Application (2017-2022)
    Table 31. Global Gestational Diabetes Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Gestational Diabetes Treatment Revenue Share by Application (2023-2028)
    Table 33. North America Gestational Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Gestational Diabetes Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Gestational Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Gestational Diabetes Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Gestational Diabetes Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Gestational Diabetes Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Gestational Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Gestational Diabetes Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Gestational Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Gestational Diabetes Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Gestational Diabetes Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Gestational Diabetes Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Gestational Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Gestational Diabetes Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Gestational Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Gestational Diabetes Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Gestational Diabetes Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Gestational Diabetes Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Gestational Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Gestational Diabetes Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Gestational Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Gestational Diabetes Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Gestational Diabetes Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Gestational Diabetes Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Gestational Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Gestational Diabetes Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Gestational Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Gestational Diabetes Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Gestational Diabetes Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Gestational Diabetes Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Biocon Limited Company Details
    Table 64. Biocon Limited Business Overview
    Table 65. Biocon Limited Gestational Diabetes Treatment Product
    Table 66. Biocon Limited Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 67. Biocon Limited Recent Developments
    Table 68. Eli Lilly Company Details
    Table 69. Eli Lilly Business Overview
    Table 70. Eli Lilly Gestational Diabetes Treatment Product
    Table 71. Eli Lilly Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 72. Eli Lilly Recent Developments
    Table 73. Novo Nordisk Company Details
    Table 74. Novo Nordisk Business Overview
    Table 75. Novo Nordisk Gestational Diabetes Treatment Product
    Table 76. Novo Nordisk Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 77. Novo Nordisk Recent Developments
    Table 78. Boehringer Ingelheim GmbH Company Details
    Table 79. Boehringer Ingelheim GmbH Business Overview
    Table 80. Boehringer Ingelheim GmbH Gestational Diabetes Treatment Product
    Table 81. Boehringer Ingelheim GmbH Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 82. Boehringer Ingelheim GmbH Recent Developments
    Table 83. Sanofi S.A. Company Details
    Table 84. Sanofi S.A. Business Overview
    Table 85. Sanofi S.A. Gestational Diabetes Treatment Product
    Table 86. Sanofi S.A. Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 87. Sanofi S.A. Recent Developments
    Table 88. Sun Pharmaceutical Industries Limited Company Details
    Table 89. Sun Pharmaceutical Industries Limited Business Overview
    Table 90. Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Product
    Table 91. Sun Pharmaceutical Industries Limited Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 92. Sun Pharmaceutical Industries Limited Recent Developments
    Table 93. Merck Company Details
    Table 94. Merck Business Overview
    Table 95. Merck Gestational Diabetes Treatment Product
    Table 96. Merck Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 97. Merck Recent Developments
    Table 98. Novartis Company Details
    Table 99. Novartis Business Overview
    Table 100. Novartis Gestational Diabetes Treatment Product
    Table 101. Novartis Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 102. Novartis Recent Developments
    Table 103. Adocia Company Details
    Table 104. Adocia Business Overview
    Table 105. Adocia Gestational Diabetes Treatment Product
    Table 106. Adocia Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 107. Adocia Recent Developments
    Table 108. Peptron Company Details
    Table 109. Peptron Business Overview
    Table 110. Peptron Gestational Diabetes Treatment Product
    Table 111. Peptron Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 112. Peptron Recent Developments
    Table 113. AstraZeneca plc Company Details
    Table 114. AstraZeneca plc Business Overview
    Table 115. AstraZeneca plc Gestational Diabetes Treatment Product
    Table 116. AstraZeneca plc Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 117. AstraZeneca plc Recent Developments
    Table 118. Pfizer, Inc Company Details
    Table 119. Pfizer, Inc Business Overview
    Table 120. Pfizer, Inc Gestational Diabetes Treatment Product
    Table 121. Pfizer, Inc Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 122. Pfizer, Inc Recent Developments
    Table 123. Takeda Pharmaceutical Company Ltd Company Details
    Table 124. Takeda Pharmaceutical Company Ltd Business Overview
    Table 125. Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Product
    Table 126. Takeda Pharmaceutical Company Ltd Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 127. Takeda Pharmaceutical Company Ltd Recent Developments
    Table 128. Abbott Company Details
    Table 129. Abbott Business Overview
    Table 130. Abbott Gestational Diabetes Treatment Product
    Table 131. Abbott Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 132. Abbott Recent Developments
    Table 133. Antares Pharma Company Details
    Table 134. Antares Pharma Business Overview
    Table 135. Antares Pharma Gestational Diabetes Treatment Product
    Table 136. Antares Pharma Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 137. Antares Pharma Recent Developments
    Table 138. INJEX Pharma AG Company Details
    Table 139. INJEX Pharma AG Business Overview
    Table 140. INJEX Pharma AG Gestational Diabetes Treatment Product
    Table 141. INJEX Pharma AG Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 142. INJEX Pharma AG Recent Developments
    Table 143. Daiichi Sankyo Company Details
    Table 144. Daiichi Sankyo Business Overview
    Table 145. Daiichi Sankyo Gestational Diabetes Treatment Product
    Table 146. Daiichi Sankyo Revenue in Gestational Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 147. Daiichi Sankyo Recent Developments
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gestational Diabetes Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Insulin Features
    Figure 3. SGLT-2 Inhibitors Features
    Figure 4. Alpha-glucosidase Inhibitors Features
    Figure 5. Others Features
    Figure 6. Global Gestational Diabetes Treatment Market Share by Application: 2021 VS 2028
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Retail Pharmacies Case Studies
    Figure 9. Online Pharmacies Case Studies
    Figure 10. Gestational Diabetes Treatment Report Years Considered
    Figure 11. Global Gestational Diabetes Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Gestational Diabetes Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Gestational Diabetes Treatment Market Share by Region: 2021 VS 2028
    Figure 14. Global Gestational Diabetes Treatment Market Share by Players in 2021
    Figure 15. Global Top Gestational Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gestational Diabetes Treatment as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Gestational Diabetes Treatment Revenue in 2021
    Figure 17. North America Gestational Diabetes Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Gestational Diabetes Treatment Market Size Market Share by Type (2017-2028)
    Figure 19. North America Gestational Diabetes Treatment Market Size Market Share by Application (2017-2028)
    Figure 20. North America Gestational Diabetes Treatment Market Size Share by Country (2017-2028)
    Figure 21. United States Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Gestational Diabetes Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Gestational Diabetes Treatment Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Gestational Diabetes Treatment Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Gestational Diabetes Treatment Market Size Share by Country (2017-2028)
    Figure 27. Germany Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Gestational Diabetes Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Gestational Diabetes Treatment Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Gestational Diabetes Treatment Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Gestational Diabetes Treatment Market Size Share by Region (2017-2028)
    Figure 37. China Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Gestational Diabetes Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Gestational Diabetes Treatment Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Gestational Diabetes Treatment Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Gestational Diabetes Treatment Market Size Share by Country (2017-2028)
    Figure 47. Mexico Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Gestational Diabetes Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Gestational Diabetes Treatment Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Gestational Diabetes Treatment Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Gestational Diabetes Treatment Market Size Share by Country (2017-2028)
    Figure 53. Turkey Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Gestational Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Biocon Limited Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 57. Eli Lilly Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 58. Novo Nordisk Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 59. Boehringer Ingelheim GmbH Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 60. Sanofi S.A. Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 61. Sun Pharmaceutical Industries Limited Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 62. Merck Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 63. Novartis Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 64. Adocia Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 65. Peptron Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 66. AstraZeneca plc Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 67. Pfizer, Inc Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 68. Takeda Pharmaceutical Company Ltd Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 69. Abbott Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 70. Antares Pharma Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 71. INJEX Pharma AG Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 72. Daiichi Sankyo Revenue Growth Rate in Gestational Diabetes Treatment Business (2017-2022)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biocon Limited
Eli Lilly
Novo Nordisk
Boehringer Ingelheim GmbH
Sanofi S.A.
Sun Pharmaceutical Industries Limited
Merck
Novartis
Adocia
Peptron
AstraZeneca plc
Pfizer, Inc
Takeda Pharmaceutical Company Ltd
Abbott
Antares Pharma
INJEX Pharma AG
Daiichi Sankyo
Frequently Asked Questions
Gestational Diabetes Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gestational Diabetes Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gestational Diabetes Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports